Login / Signup

SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART).

Kathryn MaitlandMainga M HamalubaNchafatso Gikenyi ObonyoEmmanuel OgudaChristabel MogokaThomas N WilliamsMike ChapondaSam MitiLuc Kambale KamavuJonathan GwasupikaRoisin ConnonDiana M GibbArjen M DondorpNicholas Philip John DayNicholas J WhiteA Sarah WalkerElizabeth C Georgenull null
Published in: Wellcome open research (2024)
PACTR number: 202007890194806 (date 20/07/2020) ISRCTN32271864 (date 28/07/2021).
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • young adults
  • early onset
  • open label
  • combination therapy
  • human health
  • risk assessment
  • replacement therapy